BioCentury | Apr 30, 2012
Company News

Aspen Pharmaceutical Holdings Ltd., GlaxoSmithKline sales and marketing update

...million) in cash. Business: Generics GSK divested non-core consumer healthcare OTC products in Europe to Omega Pharma N.V....
BioCentury | Mar 19, 2012
Company News

GlaxoSmithKline, Omega Pharma deal

...million ($668 million) in cash (see BioCentury, Jan. 2). GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Omega Pharma N.V....
Items per page:
1 - 2 of 2
BioCentury | Apr 30, 2012
Company News

Aspen Pharmaceutical Holdings Ltd., GlaxoSmithKline sales and marketing update

...million) in cash. Business: Generics GSK divested non-core consumer healthcare OTC products in Europe to Omega Pharma N.V....
BioCentury | Mar 19, 2012
Company News

GlaxoSmithKline, Omega Pharma deal

...million ($668 million) in cash (see BioCentury, Jan. 2). GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Omega Pharma N.V....
Items per page:
1 - 2 of 2